+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Multiomics Market

  • PDF Icon

    Report

  • 149 Pages
  • September 2024
  • Region: Global
  • BCC Research
  • ID: 5998381
Description Jump to:

The global market for multiomics is expected to grow from $2.7 billion in 2024 and is projected to reach $5.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.5% during the forecast period of 2024 to 2029.

  • The global market for multiomics for consumables is expected to grow from $1.6 billion in 2024 and is projected to reach $3.1 billion by the end of 2029, at a CAGR of 14.1% during the forecast period of 2024 to 2029.
  • The global market for multiomics for instruments is expected to grow from $629.9 million in 2024 and is projected to reach $1.1 billion by the end of 2029, at a CAGR of 12.4% during the forecast period of 2024 to 2029.

The therapeutics development process is witnessing significant transition toward a more comprehensive and holistic understanding of the disease microenvironment from a simplified and genomic-focused approach, thus creating a massive demand for multiomics technologies. Multiomics is a relatively emerging field with tremendous growth potential due to its promising applications. Established players have already entered the market by introducing multiomics products, software and services.

The multiomics market is set to gain momentum due to the adoption of multiomics technologies and products in various fields, including biomedical research and pharmaceutical development, coupled with increasing research investments, expanding applications across multiple sectors, collaborative initiatives, and technological advancements.

Report Scope

This report covers the global market for multiomics segments based on products, platforms, applications, end-users, and regions. This research report incorporates an in-depth analysis of the multiomics market, including market estimations and trends through 2029. By geography, the market in this report is divided into four regions: North America, Europe, Asia-Pacific, and Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029.

Major players, products, platforms, applications, market dynamics, and geographic opportunities are discussed in detail in the report. This report also examines various analytical frameworks such as PESTEL analysis, ESG analysis, competitive analysis, and strategic recommendations, which will aid the companies in devising their strategic plan of action.

The report includes:

  • 51 data tables and 55 additional tables
  • An analysis of the current and future global markets for multiomics
  • Analyses of global market trends, with market revenue data (sales figures) for 2021-2023, estimates for 2024, and projected CAGRs through 2029
  • Estimates of the market size and revenue forecasts for the global multiomics market, with market share analysis by product, type, platform, end-user, application and region
  • Discussion of the applications of multiomics in research studies such as analyzing many omics datasets, integrating data from genomes, transcriptomics, epigenetics, and proteomics. This in turn provides more precise information to identify causal alterations, and by exposing the etiology of the disease, can lead to the possible treatment options
  • Discussions of the market dynamics, opportunities, and challenges, as well as emerging technologies
  • Overview of sustainability trends and ESG developments in the industry, with emphasis on the ESG practices of leading companies, their ESG rankings, and consumer attitudes
  • Competitive intelligence, including companies’ market shares, recent M&A activity, and venture funding
  • Profiles of the leading companies, including Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., and F. Hoffman-La Roche Ltd.

Table of Contents

Chapter 1 Executive Summary
  • Market Outlook
  • Scope of Report
  • Market Summary
Chapter 2 Market Overview
  • Overview
  • Technology Background
  • Omics Types
  • Various Multiomics Approaches and Applications
  • Technological Infrastructure and Data Integration
  • PESTEL Analysis
  • Political
  • Economic
  • Social
  • Technological
  • Environmental
  • Legal
  • Regulatory Landscape
  • Federal Regulation
  • CMS Regulation
  • U.S. Food and Drug Administration Regulation
  • U.S. Federal Trade Commission Regulation
  • Strategic Recommendations
Chapter 3 Market Dynamics
  • Market Dynamics
    • Market Drivers
      • Rapid Advances in Multiomics Research and its Applications
      • Favorable Funding Scenario for Multiomics Research Activities
      • Decrease in DNA-Sequencing Method Prices
      • Growing Prevalence of Cancer Generating Demand for Personalized Treatments
      • Promising Applications of Multiomics in the Drug Development Process
    • Market Restraints
      • Lack of Data Standardization
    • Market Opportunities
      • Expanding Single-Cell Multiomics Applications
Chapter 4 Emerging Technologies and Developments
  • Artificial Intelligence in Multiomics
  • Companies in the Artificial Intelligence Multiomics Market
  • Advances in Single-Cell Omics and Multiomics
Chapter 5 Market Segmentation Analysis
  • Key Market Trends
  • Segmentation Breakdown
  • Global Market for Multiomics by Product
    • Instruments
    • Consumables
    • Software and Services
  • Global Market for Multiomics by Platform
    • Genomics
    • Proteomics
    • Transcriptomics
    • Metabolomics
    • Other Platforms
  • Global Market for Multiomics by Application
    • Oncology
    • Immunology
    • Neurology
    • Cell Biology
    • Other Applications
  • Global Market for Multiomics by End User
    • Academic Research Organizations
    • Pharmaceutical and Biotechnology Companies
    • Clinical and Hospital Laboratories
    • Other End Users
  • Geographic Breakdown
  • Global Multiomics Market by Region
    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World
Chapter 6 Competitive Intelligence
  • Top Players Ranking
  • Key Strategies Adopted by Players
  • Collaborations and Partnerships
  • New Product Launches
  • Expansions and Investments
  • Mergers and Acquisitions
  • Agreements
  • Patent Analysis
Chapter 7 Sustainability in Multiomics Market: ESG Perspective
  • Introduction to ESG
  • ESG Performance in Market
  • ESG Practices in the Multiomics Industry
  • Concluding Remarks
Chapter 8 Appendix
  • Methodology
  • Acronyms
  • References
Chapter 9 Company Profiles
  • Agilent Technologies Inc.
  • Beckman Coulter Inc. (Subsidiary of Danaher Corp.)
  • Bio-Rad Laboratories Inc.
  • BD
  • Bruker
  • BGI
  • F. Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Qiagen
  • Revvity
  • Standard BioTools
  • Thermo Fisher Scientific Inc.
List of Tables
Summary Table A: Global Market for Multiomics, by Product, Through 2029
Summary Table B: Global Market for Multiomics, by Region, Through 2029
Table 1: Multiomics Approaches and Their Molecular Readouts
Table 2: Molecular Biology Technologies for Multiomics Approaches
Table 3: Single-Cell and Spatial Omics Technologies, 2018-2023
Table 4: Publicly Available Omics Data in the Cancer Research Field
Table 5: Multiomics’ Role During Various Stages of Drug Development Process
Table 6: Companies in the Artificial Intelligence Multiomics Market
Table 7: Global Market for Multiomics, by Product, Through 2029
Table 8: Global Market for Multiomics for Instruments, by Region, Through 2029
Table 9: Global Market for Multiomics for Consumables, by Region, Through 2029
Table 10: Global Market for Multiomics for Software and Services, by Region, Through 2029
Table 11: Global Market for Multiomics, by Platform, Through 2029
Table 12: Global Market for Multiomics for Genomics, by Region, Through 2029
Table 13: Global Market for Multiomics for Proteomics, by Region, Through 2029
Table 14: Global Market for Multiomics for Transcriptomics, by Region, Through 2029
Table 15: Global Market for Multiomics for Metabolomics, by Region, Through 2029
Table 16: Global Market for Multiomics for Other Platforms, by Region, Through 2029
Table 17: Global Market for Multiomics, by Application, Through 2029
Table 18: Global Market for Multiomics for Oncology, by Region, Through 2029
Table 19: Global Market for Multiomics for Immunology, by Region, Through 2029
Table 20: Global Market for Multiomics for Neurology, by Region, Through 2029
Table 21: Global Market for Multiomics for Cell Biology, by Region, Through 2029
Table 22: Global Market for Multiomics for Other Applications, by Region, Through 2029
Table 23: Global Market for Multiomics, by End User, Through 2029
Table 24: Global Market for Multiomics for Academic Research Organizations, by Region, Through 2029
Table 25: Global Market for Multiomics for Pharmaceutical and Biotechnology Companies, by Region, Through 2029
Table 26: Global Market for Multiomics for Clinical and Hospital Laboratories, by Region, Through 2029
Table 27: Global Market for Multiomics for Other End Users, by Region, Through 2029
Table 28: Global Market for Multiomics, by Region, Through 2029
Table 29: North American Market for Multiomics, by Product, Through 2029
Table 30: North American Market for Multiomics, by Platform, Through 2029
Table 31: North American Market for Multiomics, by Application, Through 2029
Table 32: North American Market for Multiomics, by End User, Through 2029
Table 33: European Initiatives Focused on Omics Research for Personalized Medicine
Table 34: European Market for Multiomics, by Product, Through 2029
Table 35: European Market for Multiomics, by Platform, Through 2029
Table 36: European Market for Multiomics, by Application, Through 2029
Table 37: European Market for Multiomics, by End User, Through 2029
Table 38: Asia-Pacific Market for Multiomics, by Product, Through 2029
Table 39: Asia-Pacific Market for Multiomics, by Platform, Through 2029
Table 40: Asia-Pacific Market for Multiomics, by Application, Through 2029
Table 41: Asia-Pacific Market for Multiomics, by End User, Through 2029
Table 42: Rest of the World Market for Multiomics, by Product, Through 2029
Table 43: Rest of the World Market for Multiomics, by Platform, Through 2029
Table 44: Rest of the World Market for Multiomics, by Application, Through 2029
Table 45: Rest of the World Market for Multiomics, by End User, Through 2029
Table 46: Top Players in Multiomics Market, 2023
Table 47: Collaborations and Partnerships: Multiomics Market, 2021-2024
Table 48: New Product Launches: Multiomics Market, 2021-2024
Table 49: Expansions and Investments: Multiomics Market, 2021-2024
Table 50: Mergers and Acquisitions: Multiomics Market, 2020-2024
Table 51: Agreements: Multiomics Market, 2022-2024
Table 52: Multiomics Market: Patent Analysis, 2018-2023
Table 53: Key Focus Areas in ESG Metrics
Table 54: Environmental Performance Initiatives in the Multiomics Market, 2022 and 2023
Table 55: Social Performance Initiatives in the Multiomics Market, 2022 and 2023
Table 56: Governance Performance Initiatives in the Multiomics Market, 2022 and 2023
Table 57: ESG Rankings for Multiomics Companies, 2024*
Table 58: Acronyms Used in this Report
Table 59: Agilent Technologies Inc.: Company Snapshot
Table 60: Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 61: Agilent Technologies Inc.: Product Portfolio
Table 62: Agilent Technologies Inc.: News/Key Developments, 2023
Table 63: Beckman Coulter Inc. (Subsidiary of Danaher Corp.): Company Snapshot
Table 64: Beckman Coulter Inc. (Subsidiary of Danaher Corp.): Product Portfolio
Table 65: Beckman Coulter Inc. (Subsidiary of Danaher Corp.): News/Key Developments, 2023
Table 66: Bio-Rad Laboratories Inc.: Company Snapshot
Table 67: Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 68: Bio-Rad Laboratories Inc.: Product Portfolio
Table 69: Bio-Rad Laboratories Inc.: News/Key Developments, 2020
Table 70: BD: Company Snapshot
Table 71: BD: Financial Performance, FY 2022 and 2023
Table 72: BD: Product Portfolio
Table 73: BD: News/Key Developments, 2024
Table 74: Bruker: Company Snapshot
Table 75: Bruker: Financial Performance, FY 2022 and 2023
Table 76: Bruker: Product Portfolio
Table 77: Bruker: News/Key Developments, 2024
Table 78: BGI: Company Snapshot
Table 79: BGI: Product Portfolio
Table 80: BGI: News/Key Developments, 2024
Table 81: F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 82: F. Hoffman-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 83: F. Hoffman-La Roche Ltd.: Product Portfolio
Table 84: F. Hoffman-La Roche Ltd.: News/Key Developments, 2022
Table 85: Illumina Inc.: Company Snapshot
Table 86: Illumina Inc.: Financial Performance, FY 2022 and 2023
Table 87: Illumina Inc.: Product Portfolio
Table 88: Illumina Inc.: News/Key Developments, 2023
Table 89: QIAGEN: Company Snapshot
Table 90: QIAGEN: Financial Performance, FY 2022 and 2023
Table 91: QIAGEN: Product Portfolio
Table 92: QIAGEN: News/Key Developments, 2024
Table 93: Revvity: Company Snapshot
Table 94: Revvity: Financial Performance, FY 2022 and 2023
Table 95: Revvity: Product Portfolio
Table 96: Revvity: News/Key Developments, 2023
Table 97: Standard BioTools: Company Snapshot
Table 98: Standard BioTools: Financial Performance, FY 2022 and 2023
Table 99: Standard BioTools: Product Portfolio
Table 100: Standard BioTools: News/Key Developments, 2024
Table 101: Thermo Fisher Scientific Inc.: Company Snapshot
Table 102: Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 103: Thermo Fisher Scientific Inc.: Product Portfolio
Table 104: Thermo Fisher Scientific Inc.: News/Key Developments, 2024

List of Figures
Summary Figure A: Global Market for Multiomics, by Product, 2021-2029
Summary Figure B: Global Market for Multiomics, by Region, 2021-2029
Figure 1: Omics Types
Figure 2: Applications of Multiomics Approaches
Figure 3: PESTEL Analysis: Multiomics Market
Figure 4: Strategic Recommendations: Multiomics Market
Figure 5: Multiomics Market Dynamics
Figure 6: Average Cost Per Genome: Year-on-Year Trend, 2011-2022
Figure 7: Global Market Shares for Multiomics, by Product, 2024
Figure 8: Global Market for Multiomics for Instruments, by Region, 2021-2029
Figure 9: Global Market for Multiomics for Consumables, by Region, 2021-2029
Figure 10: Global Market for Multiomics for Software and Services, by Region, 2021-2029
Figure 11: Global Market Shares for Multiomics, by Platform, 2024
Figure 12: Global Market for Multiomics for Genomics, by Region, 2021-2029
Figure 13: Global Market for Multiomics for Proteomics, by Region, 2021-2029
Figure 14: Global Market for Multiomics for Transcriptomics, by Region, 2021-2029
Figure 15: Global Market for Multiomics for Metabolomics, by Region, 2021-2029
Figure 16: Global Market for Multiomics for Other Platforms, by Region, 2021-2029
Figure 17: Major Applications of Multiomics
Figure 18: Global Market Shares for Multiomics, by Application, 2024
Figure 19: Global Market for Multiomics for Oncology, by Region, 2021-2029
Figure 20: Global Market for Multiomics for Immunology, by Region, 2021-2029
Figure 21: Global Market for Multiomics for Neurology, by Region, 2021-2029
Figure 22: Global Market for Multiomics for Cell Biology, by Region, 2021-2029
Figure 23: Global Market for Multiomics for Other Applications, by Region, 2021-2029
Figure 24: Global Market Shares for Multiomics, by End User, 2024
Figure 25: Global Market for Multiomics for Academic Research Organizations, by Region, 2021-2029
Figure 26: Global Market for Multiomics for Pharmaceutical and Biotechnology Companies, by Region, 2021-2029
Figure 27: Global Market for Multiomics for Clinical and Hospital Laboratories, by Region, 2021-2029
Figure 28: Global Market for Multiomics for Other End Users, by Region, 2021-2029
Figure 29: Global Market Shares of Multiomics, by Region, 2024
Figure 30: North American Market for Multiomics, by Product, 2021-2029
Figure 31: North American Market for Multiomics, by Platform, 2021-2029
Figure 32: North American Market for Multiomics, by Application, 2021-2029
Figure 33: North American Market for Multiomics, by End User, 2021-2029
Figure 34: European Market for Multiomics, by Product, 2021-2029
Figure 35: European Market for Multiomics, by Platform, 2021-2029
Figure 36: European Market for Multiomics, by Application, 2021-2029
Figure 37: European Market for Multiomics, by End User, 2021-2029
Figure 38: Asia-Pacific Multiomics Market Growth Drivers
Figure 39: Asia-Pacific Market for Multiomics, by Product, 2021-2029
Figure 40: Asia-Pacific Market for Multiomics, by Platform, 2021-2029
Figure 41: Asia-Pacific Market for Multiomics, by Application, 2021-2029
Figure 42: Asia-Pacific Market for Multiomics, by End User, 2021-2029
Figure 43: Rest of the World Market for Multiomics, by Product, 2021-2029
Figure 44: Rest of the World Market for Multiomics, by Platform, 2021-2029
Figure 45: Rest of the World Market for Multiomics, by Application, 2021-2029
Figure 46: Rest of the World Market for Multiomics, by End User, 2021-2029
Figure 47: Global Multiomics Market Competitive Intelligence, 2020-2024
Figure 48: Patents, 2018-2023
Figure 49: How a Strong ESG Proposition Benefits Businesses
Figure 50: Biotech Companies Providing ESG Disclosure, 2022
Figure 51: Location of ESG Disclosure, 2022
Figure 52: Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 53: Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 54: Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 55: Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 56: BD: Revenue Share, by Business Unit, FY 2023
Figure 57: BD: Revenue Share, by Country/Region, FY 2023
Figure 58: Bruker: Revenue Share, by Business Unit, FY 2023
Figure 59: Bruker: Revenue Share, by Country/Region, FY 2023
Figure 60: F. Hoffman-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 61: F. Hoffman-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 62: Illumina Inc.: Revenue Share, by Business Unit, FY 2023
Figure 63: Illumina Inc.: Revenue Share, by Country/Region, FY 2023
Figure 64: QIAGEN: Revenue Share, by Business Unit, FY 2023
Figure 65: QIAGEN: Revenue Share, by Country/Region, FY 2023
Figure 66: Revvity: Revenue Share, by Business Unit, FY 2023
Figure 67: Revvity: Revenue Share, by Country/Region, FY 2023
Figure 68: Standard BioTools: Revenue Share, by Business Unit, FY 2023
Figure 69: Standard BioTools: Revenue Share, by Country/Region, FY 2023
Figure 70: Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 71: Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023

Samples

Loading
LOADING...

Companies Mentioned

  • Agilent Technologies Inc.
  • Beckman Coulter Inc. (Subsidiary of Danaher Corp.)
  • Bio-Rad Laboratories Inc.
  • BD
  • Bruker
  • BGI
  • F. Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Qiagen
  • Revvity
  • Standard BioTools
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages149
PublishedSeptember 2024
Forecast Period2024 - 2029
Estimated Market Value ( USD ) in 2024 $ 2.7 Billion
Forecasted Market Value ( USD ) by 2029 $ 5.1 Billion
Compound Annual Growth Rate13.5%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

Multiomics Global Market Report 2024 - Product Image

Multiomics Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Global Multiomics Market by Product (Consumables, Instrument, Software), Type (Epigenomics, Genomics, Metabolomics), Application, End-User - Forecast 2024-2030 - Product Image

Global Multiomics Market by Product (Consumables, Instrument, Software), Type (Epigenomics, Genomics, Metabolomics), Application, End-User - Forecast 2024-2030

  • Report
  • 198 Pages
  • Global
From
Global Multiomics Market Size, Share & Industry Trends Analysis Report By Type (Bulk Multiomics, and Single-cell Multiomics), By Product & Service, By End-use, By Platform, By Application, By Regional Outlook and Forecast, 2023 - 2030 - Product Image

Global Multiomics Market Size, Share & Industry Trends Analysis Report By Type (Bulk Multiomics, and Single-cell Multiomics), By Product & Service, By End-use, By Platform, By Application, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • Global
From
Global Multiomics Market - Product Image

Global Multiomics Market

  • Report
  • 200 Pages
  • Global
From
Multiomics Market Size, Share & Trends Analysis Report By Product & Service (Instruments, Consumables), By Type (Single-cell, Bulk), By Platform, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Multiomics Market Size, Share & Trends Analysis Report By Product & Service (Instruments, Consumables), By Type (Single-cell, Bulk), By Platform, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.